This announcement is a separate document:
昂利康:浙江天册律师事务所关于浙江昂利康制药股份有限公司2023年度股东大会的法律意见书
Zhejiang Anglikang Pharmaceutical: Legal Opinion of Zhejiang Tianze Law Firm on the 2023 Annual General Meeting of Shareholders of Zhejiang Anglikang Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.